Bilateral Erector Spinae Plane Block as an Opioid Sparing Technique for Selective Dorsal Rhizotomy in Pediatric Patients With Spastic Cerebral Palsy

Launched by TANTA UNIVERSITY · Sep 17, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a technique called the bilateral erector spinae plane block, which aims to reduce the need for opioids in children undergoing a specific surgery called selective dorsal rhizotomy. This surgery is often performed on kids with spastic cerebral palsy, a condition that affects movement and muscle control. By using this technique, the researchers hope to manage pain more effectively and safely, minimizing the use of strong pain medication like opioids.

To participate in this trial, children must be between the ages of 6 and 18 and have spastic cerebral palsy. They should also be in good overall health, as defined by certain medical guidelines. However, those with allergies to local anesthetics, severe joint deformities, or issues with their liver or kidneys are not eligible. If your child qualifies and decides to participate, they will receive the erector spinae plane block during their surgery, and the study will monitor how well it works in helping to control pain without relying heavily on opioids.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age from 6 to 18 years.
• • Both sexes.
• • American Society of Anesthesiology (ASA) physical status II, III.
• • Patients with spastic cerebral palsy undergoing selective dorsal rhizotomy.
• Exclusion Criteria:
• • Allergy to local anesthetics.
• • Severe fixed joint deformity.
• • Previous orthopedic surgery.
• • Patient with abnormal liver/kidney function.
• • Patient with skin damage or infection at the proposed puncture site.